From ‘Histiocytosis X’ to modern myeloid neoplasm: a high-yield guide to Langerhans Cell Histiocytosis pathophysiology, diagnosis, and management for medical students.
White Blood Cells
Tumor Lysis Syndrome (TLS)
Tumor Lysis Syndrome or TLS: An oncologic emergency where rapid cell death causes metabolic chaos.
Hemophagocytic Lymphohistiocytosis (HLH)
Unmask the HLH cytokine storm. Master pathophysiology, the HScore, and life-saving management in this high-yield guide for medical learners.
Langerhans Cell Histiocytosis (Histiocytosis X)
From ‘Histiocytosis X’ to modern myeloid neoplasm: a high-yield guide to Langerhans Cell Histiocytosis pathophysiology, diagnosis, and management for medical students.
Tumor Lysis Syndrome (TLS)
Tumor Lysis Syndrome or TLS: An oncologic emergency where rapid cell death causes metabolic chaos.
Plasma Cell
The plasma cell is the terminal B-lymphocyte, the immune system’s antibody factory for mass Ig secretion, recognized by its eccentric nucleus.
Neutropenic Sepsis
Neutropenic sepsis is a medical emergency requiring rapid intervention. This guide covers vital definitions, the “Sepsis Six” management bundle, and clinical indicators to help you recognize and treat this life-threatening condition promptly.
Plasma Cell
The plasma cell is the terminal B-lymphocyte, the immune system’s antibody factory for mass Ig secretion, recognized by its eccentric nucleus.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
MGUS is an asymptomatic clonal disorder. It is the precursor to Multiple Myeloma, requiring only active surveillance and risk monitoring.
Smoldering Multiple Myeloma (SMM)
Smoldering Multiple Myeloma (SMM) is an asymptomatic precursor to MM, defined by high clonal plasma cell burden and M-protein without MDEs. Risk stratification is key.
Acute Lymphoblastic Leukemia or ALL
Acute Lymphoblastic Leukemia (ALL) is a cancer of immature white blood cells. Learn its cause, symptoms, and modern treatment, including CAR T-cell therapy.
Chediak-Higashi Syndrome
Chediak-Higashi syndrome (CHS) is a rare genetic disorder characterized by oculocutaneous albinism, immune deficiency, and neurological decline.